Tumor
Conditions
Interventions
Ganoderma lucidum spore powder + enteral nutrition powder group:Ganoderma lucidum spore powder
Enteral nutrition powder group:Enteral nutrition powder
Sponsors
The University of Hong Kong-Shenzhen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1: All cases are subject to pathology and or cytology for a diagnosis of malignant tumorpathological type is not restricted; 2: Aged 18 years or above; 3: Expected survival time longer than 6 months; 4: Undergoing palliative care; 5: Have a functional digestive tract.
Exclusion criteria
Exclusion criteria: 1: Disseminated intravascular coagulation or severe thrombocytopenia with a bleeding tendency ie low platelet count 35000L INR 15 hemoglobin90 gdL; 2: Inability to swallow medicinal capsules; 3: Non-functional digestive tract (tumor compression, gastrointestinal obstruction); 4: Patients with gastrointestinal tumors; 5: Inability to read and understand Chinese; 6: Severe cognitive impairment(SLUMS <=20); 7: Not given written informed consent; 8: Allergy to ganoderma lucidum spore powder, milk or soy protein is known; 9: Galactosemia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| quality of life; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cancer related symptoms; | — |
Countries
China
Contacts
Public ContactFengming Kong
The University of Hong Kong-Shenzhen Hospital
Outcome results
None listed